• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Bcm Europe Ag claimed ownership of 7,531,634 shares (SEC Form 3)

    2/19/25 9:08:37 PM ET
    $BLAC
    Blank Checks
    Finance
    Get the next $BLAC alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    BCM Europe AG

    (Last) (First) (Middle)
    GOTTHARDSTRASSE 26 6300

    (Street)
    ZUG SWITZERLAND

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    02/14/2025
    3. Issuer Name and Ticker or Trading Symbol
    OSR Holdings, Inc. [ OSRH ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 7,531,634(1) D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares of OSR Holdings, Inc. common stock acquired by BCM Europe AG in exchange for its shares of OSR Holdings Co., Ltd. common stock at the closing of the business combination between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd.
    /s/ Kuk Hyoun Hwang Managing Member 02/19/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BLAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLAC
    SEC Filings

    See more
    • Bellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Leadership Update, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits

      8-K - OSR Holdings, Inc. (0001840425) (Filer)

      2/21/25 4:10:12 PM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 25-NSE filed by Bellevue Life Sciences Acquisition Corp.

      25-NSE - OSR Holdings, Inc. (0001840425) (Subject)

      2/18/25 8:16:26 AM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 425 filed by Bellevue Life Sciences Acquisition Corp.

      425 - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      2/13/25 4:14:40 PM ET
      $BLAC
      Blank Checks
      Finance

    $BLAC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

      OSR Holdings, Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday, February 18, 2025Under the symbol "OSRH" SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR Holdings Co., Ltd. ("OSR") announced today the completion of their business combination (the "Business Combination"). The Company now operates as "OSR Holdings, Inc." following the successful completion of the Business Combination.  Beginning on Tuesday, February 18, 2025, the common stock and warrants of the Company

      2/14/25 6:10:00 PM ET
      $BLAC
      Blank Checks
      Finance
    • Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.

      SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders (the "Special Meeting") held today, including the proposal for the business combination with OSR Holdings Co., Ltd. (the "Transaction").  BLAC expects the Transaction to close following receipt of foreign investment approval from the Industrial Bank of Korea, which is expected on February 14, 2025.  Following the Special Meeting, BLAC filed its Amended and Restated Certific

      2/13/25 4:10:00 PM ET
      $BLAC
      Blank Checks
      Finance
    • Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting

      BELLEVUE, Wash., May 13, 2024 /PRNewswire/ -- As previously announced, on May 10, 2024, Bellevue Life Sciences Acquisitions Corp. (NASDAQ:BLAC) ("BLAC") convened a special meeting of stockholders (the "Special Meeting"), adjourned the Special Meeting without any business being conducted, and announced that the Special Meeting will be reconvened at 9:00 a.m. Pacific time on Tuesday, May 14, 2024, at 925 Fourth Avenue, Suite 2900, Seattle, WA 98104. At the reconvened Special Meeting, stockholders will consider and vote upon the matters described in BLAC's definitive proxy statement filed with the U.S. Securities and Exchange Commission (the "SEC") on April 26, 2024 (the "Proxy Statement"). BL

      5/13/24 9:05:00 AM ET
      $BLAC
      Blank Checks
      Finance

    $BLAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Kim Sang Harry

      3 - OSR Holdings, Inc. (0001840425) (Issuer)

      2/21/25 4:15:09 PM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Cho Joong Myung

      3 - OSR Holdings, Inc. (0001840425) (Issuer)

      2/21/25 4:15:12 PM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Barberis Alcide

      3 - OSR Holdings, Inc. (0001840425) (Issuer)

      2/21/25 4:15:10 PM ET
      $BLAC
      Blank Checks
      Finance

    $BLAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Bellevue Life Sciences Acquisition Corp.

      SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      11/14/24 4:47:55 PM ET
      $BLAC
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Bellevue Life Sciences Acquisition Corp.

      SC 13G/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      8/14/24 8:00:58 AM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Bellevue Life Sciences Acquisition Corp.

      SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      2/8/24 4:20:10 PM ET
      $BLAC
      Blank Checks
      Finance